Enzyme-Prodrug Strategies for Cancer Therapy
Antibody-directed enzyme prodrug therapy (ADEPT) directly addresses the major problem in cancer chemotherapy-its lack of selectivity. Antibody delivery combined with the amplification provided by the enzymatic activation of prodrugs enables selection to be made between tumour and normal tissue. ADEPT offers a novel field of opportunities in the therapy of systemic cancer and may be a major advance for the treatment of solid tumours. This book is the first to describe ADEPT in detail. Each chapter reviews an aspect of the immunology, enzymology, biochemistry, chemistry, and cancer chemotherapy which have been integrated into the ADEP…
Mehr
CHF 264.00
Preise inkl. MwSt. und Versandkosten (Portofrei ab CHF 40.00)
V104:
Folgt in ca. 10 Arbeitstagen
Produktdetails
Weitere Autoren: Melton, Roger G. (Hrsg.)
- ISBN: 978-0-306-45895-8
- EAN: 9780306458958
- Produktnummer: 2870335
- Verlag: Springer Us
- Sprache: Englisch
- Erscheinungsjahr: 1999
- Seitenangabe: 276 S.
- Masse: H24.1 cm x B16.0 cm x D1.9 cm 582 g
- Auflage: 1999
- Abbildungen: HC runder Rücken kaschiert
- Gewicht: 582
1 weiteres Werk von Richard J. (Hrsg.) Knox:
Bewertungen
Anmelden